ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

VLON Vallon Pharmaceuticals Inc

0.40
0.00 (0.00%)
17 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Vallon Pharmaceuticals Inc VLON NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.40 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.40 0.40
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/6/202415:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/6/202415:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/6/202415:48EDGAR2Form 8-K - Current report
14/6/202407:08EDGAR2Form 8-K - Current report
07/6/202415:06EDGAR2Form 8-K - Current report
31/5/202414:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/5/202414:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/5/202415:45EDGAR2Form 8-K - Current report
20/5/202415:13EDGAR2Form 8-K - Current report
20/5/202415:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/5/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
14/5/202415:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202415:44EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/5/202407:02EDGAR2Form 8-K - Current report
10/5/202416:24EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202415:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:31EDGAR2Form DEF 14A - Other definitive proxy statements
01/4/202408:13EDGAR2Form 8-K - Current report
28/3/202415:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/3/202415:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/202415:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/202415:23EDGAR2Form 8-K - Current report
02/2/202415:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/1/202407:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/1/202407:12EDGAR2Form 8-K - Current report
19/1/202415:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/1/202415:15EDGAR2Form 8-K - Current report
16/1/202407:45EDGAR2Form 8-K - Current report
20/12/202316:12EDGAR2Form PRE 14A - Other preliminary proxy statements
15/12/202316:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/12/202308:07EDGAR2Form 8-K - Current report
27/11/202307:38EDGAR2Form 8-K - Current report
24/11/202315:04EDGAR2Form 8-K - Current report
15/11/202307:07EDGAR2Form 8-K - Current report
01/11/202307:45EDGAR2Form 8-K - Current report
13/10/202315:40EDGAR2Form S-3 - Registration statement under Securities Act of..
25/8/202315:42EDGAR2Form 8-K - Current report
23/8/202308:07EDGAR2Form 8-K - Current report
14/8/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202307:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202307:06EDGAR2Form 8-K - Current report
07/7/202315:03EDGAR2Form 8-K - Current report
06/7/202315:28EDGAR2Form 8-K/A - Current report: [Amend]